cetuximab,afatinib,pembrolizumab,adagrasib
mirati,boehringer ingelheim,eli lilly,merck
['krystal-1']
before the update on the krystal-1 trial this morning at #esmo22, read this news article! 
Assistant Editor of Cancer Discovery @CD_AACR published by @AACR. Trained at @FoxChaseCancer and @unmc. Proud Green Bay Packer Fan. Views are my own.